Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EBT (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of EBT data on record, last reported at $2.9 million in Q4 2025.

  • For Q4 2025, EBT rose 122.79% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $91.5 million, up 114.15%, while the annual FY2025 figure was $91.5 million, 114.15% up from the prior year.
  • EBT reached $2.9 million in Q4 2025 per TCNNF's latest filing, down from $29.3 million in the prior quarter.
  • Across five years, EBT topped out at $70.0 million in Q2 2021 and bottomed at -$308.2 million in Q2 2023.
  • Average EBT over 5 years is $432850.0, with a median of $13.4 million recorded in 2022.
  • Peak YoY movement for EBT: plummeted 1585.67% in 2023, then surged 2644.5% in 2024.
  • A 5-year view of EBT shows it stood at -$18.6 million in 2021, then soared by 63.76% to -$6.7 million in 2022, then surged by 231.01% to $8.8 million in 2023, then tumbled by 246.25% to -$12.9 million in 2024, then surged by 122.79% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $2.9 million in Q4 2025, $29.3 million in Q3 2025, and $38.9 million in Q2 2025.